| Assessment of the Effect of Interferon-Beta1a Therapy on Thyroid and Salivary Gland Functions in Patients with Multiple Sclerosis Using Quantitative Salivary Gland Scintigraphyz | SEVAL ERHAMAMCI,Bahriye HORASANLI,Ayşe AKTAŞ | 43–47 |
| Evaluation of Awareness on Radiation Protection and Knowledge About Radiological Examinations in Healthcare Professionals Who Use Ionized Radiation at Work | AYŞEGÜL YURT,Berrin ÇAVUŞOĞLU,TÜRKAN GÜNAY | 48–53 |
| Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer | Isa Neshandar ASLİ,Ali Shafiepour SİAHKALİ,Babak SHAFİE,Hamid JAVADİ,Majid ASSADİ | 54–59 |
| Radiation Levels from Toilets Used By Patients Injected with 99mTcbased Radiopharmaceuticals in Ibadan | Tolulope Hadrat ABİODUN,Kayode Solomon ADEDAPO,Yetunde Ajoke ONİMODE,Olusegun Akinwale AYENİ,John Enyi EJEH | 60–63 |
| Schwannomatozis of the Chest Wall: FDG PET Findings | Seyfettin ILGAN,ERKAN DİKMEN,Cihan Genco ÇETİNKANAT,Mehmet DAKAK,Adem GÜNGÖR | 64–66 |
| Detection of Hodgkin Transformation in a Case of Chronic Lymphocytic Leukemia by PET/CT | Sabire YILMAZ,Meftune ÖZHAN,Sertaç ASA,M. Sait SAĞER,Fatih Selçuk BİRİCİK,Metin HALAÇ,KERİM SÖNMEZOĞLU | 67–69 |
| Multimodality Imaging in an Adult Patient with Scimitar Syndrome | ALPER ÖZGÜR KARAÇALIOĞLU,Seyfettin GÜMÜŞ,SEMRA İNCE,Sait DEMİRKOL | 70–73 |
| The Importance of FDG-PET/CT in Cogan's Syndrome | Ebru ÖRSAL,Mahir UĞUR,Bedri SEVEN,Arif Kürşad AYAN,Fatma İÇYER,Aslı YILDIZ | 74–75 |
| The Importance of FDG-PET/CT in Cogan's Syndrome | Aslı YILDIZ, Mahir UĞUR, Bedri SEVEN, Ebru ÖRSAL, Arif Kürşad AYAN, Fatma İÇYER | 74–75 |